home

Are you at risk?

Peripheral Artery Disease (PAD) testing Peripheral Artery Disease (PAD) testing

Janssen Cardiovascular and Metabolism (CVM) U.S. Medical Affairs has partnered with U.S. Mobile Health Exams to provide free Peripheral Artery Disease (PAD) screening to at-risk communities using a traveling mobile health unit. This Johnson & Johnson CREDO inspired initiative gives our team the opportunity to help raise awareness and provide PAD screening and education in communities across the country.

The EMPOWER-PAD mobile unit leverages Ankle Brachial Index (ABI) technology to help screen for PAD. It is a quick, noninvasive test that measures blood pressure in the ankle and compares it with blood pressure in the upper arm1.

Our goal is to EMPOWER community members to take a more active role in their health and ultimately live healthier lives.

1. Gerhard-Herman et al. J Am Coll Cardiol. 2017;69(11):e71-e126.

OUR GOALS

  • Engage and interact with local communities
  • Provide education and raise awareness about PAD
  • Provide ABI screening to help detect PAD
Over the next year we will complete 75 events

Peripheral Artery Disease2:

Peripheral artery disease (PAD) is caused by a narrowing of blood vessels outside the heart and brain, specifically blood vessels that carry blood to the legs and feet, arms, stomach or kidneys

Fatty buildup (atherosclerosis) in arteries causes structural changes in blood vessels which can interfere with normal blood flow

Common symptoms of PAD include cramping, fatigue, heaviness, or discomfort in the legs and buttocks which result from poor leg circulation and typically occur during activity and go away with rest

Risk factors for PAD include a history of smoking, diabetes, older age (>65 years), high blood pressure, or high cholesterol

Peripheral Artery Disease

Ankle-Brachial Index (ABI)3

ABI is a quick, noninvasive test that measures blood pressure in the ankle and compares it with blood pressure in the upper arms1

1. Gerhard-Herman et al. J Am Coll Cardiol. 2017;69(11):e71-e126.

2. American Heart Association. A Clinician’s Guide: Helping Your Patients with Peripheral Artery Disease (PAD). http://www.ksw-gtg.com/ahapad/guide/pdfs/PVDvsPAD.pdf (accessed Oct 9, 2019).

3. ABI image is from: https://www.cardiosmart.org/Heart-Conditions/Peripheral-Arterial-Disease-of-the-Legs

What to Expect

When the EMPOWER-PAD mobile unit comes to your community, here is what to expect during your visit:

1

Getting Started

You will fill out paperwork which includes a consent form you will need to sign in order to be screened. Once you have completed your paperwork, you will receive a card where you can record the results of your Ankle-Brachial Index (ABI) screening. While you wait to be screened, there will be plenty of educational materials for you to review to learn about PAD and ABI screening.

2

Now It Is Time To
Be Screened!

A technician will explain the ABI test to you and answer questions that you may have about the test. Total screening time should take less than 5 minutes. Once your screening is completed, you will record your ABI number on your card to keep for your records.

We will not be maintaining or collecting any information.

3

After Your Screening

The technician will discuss your ABI number and PAD risk factors with you, as well as provide you with additional educational resources.

If you have any questions during this process, please do not hesitate to reach out and ask an EMPOWER-PAD staff member at any time during your visit!

room

PATIENT EXPERIENCE

video

About the Janssen Pharmaceutical Companies of Johnson & Johnson

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.